These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 35917709)

  • 1. Self-deliverable and self-immolative prodrug nanoassemblies as tumor targeted nanomedicine with triple cooperative anticancer actions.
    Jung E; Jeong SW; Lee Y; Jeon C; Shin H; Song N; Lee Y; Lee D
    Biomaterials; 2022 Aug; 287():121681. PubMed ID: 35917709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanoassemblies of Self-Immolative Boronate-Bridged Retinoic Acid Dimeric Prodrug as a Clot-Targeted Self-Deliverable Antithrombotic Nanomedicine.
    Jun H; Jeon C; Kim S; Song N; Jo H; Yang M; Lee D
    ACS Nano; 2023 Jul; 17(13):12336-12346. PubMed ID: 37382227
    [No Abstract]   [Full Text] [Related]  

  • 3. H
    Jung E; Song N; Lee Y; Kwon G; Kwon S; Lee D
    Biomaterials; 2022 May; 284():121515. PubMed ID: 35429813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cascade-amplified self-immolative polymeric prodrug for cancer therapy by disrupting redox homeostasis.
    Dey A; Jeon J; Yoon B; Li Y; Park JH
    J Control Release; 2023 Jun; 358():555-565. PubMed ID: 37182804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clot-Targeted Antithrombotic Liposomal Nanomedicine Containing High Content of H
    Jeon C; Jun H; Kim S; Song N; Yang M; Lim C; Lee D
    ACS Appl Mater Interfaces; 2023 Feb; ():. PubMed ID: 36749947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reactive oxygen species-responsive nanoprodrug with quinone methides-mediated GSH depletion for improved chlorambucil breast cancers therapy.
    Luo CQ; Zhou YX; Zhou TJ; Xing L; Cui PF; Sun M; Jin L; Lu N; Jiang HL
    J Control Release; 2018 Mar; 274():56-68. PubMed ID: 29409835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Redox-sensitive prodrug nanoassemblies based on linoleic acid-modified docetaxel to resist breast cancers.
    Li M; Zhao L; Zhang T; Shu Y; He Z; Ma Y; Liu D; Wang Y
    Acta Pharm Sin B; 2019 Mar; 9(2):421-432. PubMed ID: 30972286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-targeted redox-regulating and antiangiogenic phototherapeutics nanoassemblies for self-boosting phototherapy.
    Jung E; Kwon S; Song N; Kim N; Jo H; Yang M; Park S; Kim C; Lee D
    Biomaterials; 2023 Jul; 298():122127. PubMed ID: 37086554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probing the Superiority of Diselenium Bond on Docetaxel Dimeric Prodrug Nanoassemblies: Small Roles Taking Big Responsibilities.
    Zuo S; Sun B; Yang Y; Zhou S; Zhang Y; Guo M; Sun M; Luo C; He Z; Sun J
    Small; 2020 Nov; 16(45):e2005039. PubMed ID: 33078579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A reactive oxygen species-replenishing coordination polymer nanomedicine disrupts redox homeostasis and induces concurrent apoptosis-ferroptosis for combinational cancer therapy.
    Zhang Z; Pan Y; Cun JE; Li J; Guo Z; Pan Q; Gao W; Pu Y; Luo K; He B
    Acta Biomater; 2022 Oct; 151():480-490. PubMed ID: 35926781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A self-immolative prodrug nanosystem capable of releasing a drug and a NIR reporter for in vivo imaging and therapy.
    Wang Z; Wu H; Liu P; Zeng F; Wu S
    Biomaterials; 2017 Sep; 139():139-150. PubMed ID: 28614754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo tailor-made protein corona of a prodrug-based nanoassembly fabricated by redox dual-sensitive paclitaxel prodrug for the superselective treatment of breast cancer.
    Zhang D; Yang J; Guan J; Yang B; Zhang S; Sun M; Yang R; Zhang T; Zhang R; Kan Q; Zhang H; He Z; Shang L; Sun J
    Biomater Sci; 2018 Aug; 6(9):2360-2374. PubMed ID: 30019051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prodrug-based nanoparticulate drug delivery strategies for cancer therapy.
    Luo C; Sun J; Sun B; He Z
    Trends Pharmacol Sci; 2014 Nov; 35(11):556-66. PubMed ID: 25441774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zwitterion-Driven Shape Program of Prodrug Nanoassemblies with High Stability, High Tumor Accumulation, and High Antitumor Activity.
    Li G; Sun B; Zheng S; Xu L; Tao W; Zhao D; Yu J; Fu S; Zhang X; Zhang H; Zhai Y; Luo C; Ding H; He Z; Sun J
    Adv Healthc Mater; 2021 Dec; 10(23):e2101407. PubMed ID: 34601824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel ROS-activable self-immolative prodrug for tumor-specific amplification of oxidative stress and enhancing chemotherapy of mitoxantrone.
    Zhang H; Chen W; Wang J; Du W; Wang B; Song L; Hu Y; Ma X
    Biomaterials; 2023 Feb; 293():121954. PubMed ID: 36538847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methotrexate-based amphiphilic prodrug nanoaggregates for co-administration of multiple therapeutics and synergistic cancer therapy.
    Hou M; Gao YE; Shi X; Bai S; Ma X; Li B; Xiao B; Xue P; Kang Y; Xu Z
    Acta Biomater; 2018 Sep; 77():228-239. PubMed ID: 30006314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction-Responsive Stearyl Alcohol-Cabazitaxel Prodrug Nanoassemblies for Cancer Chemotherapy.
    Liu Y; Wang X; Wang Z; Liao R; Qiu Q; Wang Y; Luo C
    Pharmaceutics; 2023 Jan; 15(1):. PubMed ID: 36678891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Photodynamic PEG-coated ROS-sensitive prodrug nanoassemblies for core-shell synergistic chemo-photodynamic therapy.
    Sun B; Chen Y; Yu H; Wang C; Zhang X; Zhao H; Chen Q; He Z; Luo C; Sun J
    Acta Biomater; 2019 Jul; 92():219-228. PubMed ID: 31078764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomimetic nanoassemblies of 1-O-octodecyl-2-conjugated linoleoyl-sn-glycero-3-phosphatidyl gemcitabine with phospholipase A
    Zuo J; Tong L; Du L; Yang M; Jin Y
    Colloids Surf B Biointerfaces; 2017 Apr; 152():467-474. PubMed ID: 28187380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Self-assembled thioether-bridged paclitaxel-dihydroartemisinin prodrug for amplified antitumor efficacy-based cancer ferroptotic-chemotherapy.
    Zheng Y; Qin C; Li F; Qi J; Chu X; Li H; Shi T; Yan Z; Yang L; Xin X; Liu L; Han X; Yin L
    Biomater Sci; 2023 May; 11(9):3321-3334. PubMed ID: 36946490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.